Europe Women's Digital Health Market By Type, By Application, By Country, Opportunity Analysis and Industry Forecast, 2021-2027

The Europe Women’s Digital Health Market is expected to witness market growth of 18.3% CAGR during the forecast period (2021-2027).

The major objectives of women's digital health technology are to encourage and assist the development and adoption of digital health products and measures among women across the world and allow them to maintain women-centric issues, diseases, and disorders in a sustainable, safe, and responsible manner. Moreover, to aware women around the world, about the ease and convenience they can experience while obtaining solutions for resolving their personal health issues that too with eliminated hesitation.

Good advancements in the field of women's health have prompted a wide group of enterprises with a variety of application areas to invest in new product R&D. This resulted in a slew of new products being introduced over upcoming years, ranging from diagnostic and monitoring equipment to treatment gadgets. As the global female demographics alter, the growing younger generation of women is expected to embrace these products in a substantial manner. These positive trends are projected to propel the global industry forward.

Due to increased knowledge of women's diseases and improved healthcare infrastructure in European countries, Europe is anticipated to become a lucrative hub for manufacturers and suppliers of women-centric digital healthcare products as well as health care service providers across the region. Additionally, the robust existence of digital technologies aiming toward enhancing the personal well-being of women is increasing.

The Germany market dominated the Europe Women’s Digital Health Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $336.1 Million by 2027. The UK market is expected to experience a CAGR of 17.5% during (2021 - 2027). Additionally, The France market is expected to witness a CAGR of 19.2% during (2021 - 2027).

Based on Type, the market is segmented into Mobile Apps, Wearable Devices, Diagnostic Tools, and Others. Based on Application, the market is segmented into Reproductive Health, General Healthcare & Wellness, Pregnancy & Nursing Care, and Pelvic Care. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include HeraMED Ltd, iSono Health, Inc., Clue by Biowink GmbH, Chiaro Technology Ltd. (Elvie), Natural Cycles USA Corp, Ava AG, NURX, Inc., Athena Feminine Technologies, Inc., MobileODT Ltd., and Lucina Health (Unified Women's Healthcare).

Scope of the Study

Market Segments Covered in the Report:

By Type

• Mobile Apps
• Wearable Devices
• Diagnostic Tools
• Others

By Application

• Reproductive Health
• General Healthcare & Wellness
• Pregnancy & Nursing Care
• Pelvic Care

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• HeraMED Ltd
• iSono Health, Inc.
• Clue by Biowink GmbH
• Chiaro Technology Ltd. (Elvie)
• Natural Cycles USA Corp
• Ava AG
• NURX, Inc.
• Athena Feminine Technologies, Inc.
• MobileODT Ltd.
• Lucina Health (Unified Women's Healthcare)

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free